نتائج البحث - Val Gebski
- يعرض 1 - 20 نتائج من 70
- اذهب إلى الاصفحة التالية
-
1
-
2
-
3
-
4
The Head Injury Retrieval Trial (HIRT): a single-centre randomised controlled trial of physician prehospital management of severe blunt head injury compared with management by para... حسب Alan Garner, K. Mann, Michael R. Fearnside, Elwyn Poynter, Val Gebski
منشور في 2015Artigo -
5
-
6
-
7
-
8
-
9
-
10
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of... حسب Peter Gibbs, Val Gebski, Mark Van Buskirk, Kenneth G. Thurston, David Cade, Guy A. Van Hazel
منشور في 2014Artigo -
11
Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device±Metformin±weight loss in endometrial cance... حسب Anna L. Hawkes, Michael Quinn, Val Gebski, Jane E. Armes, Donal J. Brennan, Monika Janda, Andreas Obermair
منشور في 2014Artigo -
12
-
13
-
14
-
15
-
16
-
17
-
18
Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen–Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Re... حسب Kenneth F. Bradstock, Ian Bilmon, John Kwan, Kenneth Micklethwaite, Emily Blyth, Stephanie Deren, Angela Bayley, Val Gebski, David Gottlieb
منشور في 2015Artigo -
19
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer حسب M. D. Green, Prudence A. Francis, Val Gebski, V. Harvey, Christos S. Karapetis, Arlene Chan, Ray Snyder, Akiko Fong, R. Basser, John Forbes
منشور في 2009Artigo -
20
Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Sm... حسب Pei N. Ding, Sarah J. Lord, Val Gebski, Matthew Links, Victoria Bray, Richard J. Gralla, James Chih‐Hsin Yang, Chee Khoon Lee
منشور في 2016Revisão
أدوات البحث:
موضوعات ذات صلة
Medicine
Internal medicine
Cancer
Oncology
Surgery
Chemotherapy
Randomized controlled trial
Confidence interval
Hazard ratio
Biology
Gastroenterology
Clinical endpoint
Clinical trial
Colorectal cancer
Environmental health
Pathology
Population
Gynecology
Adverse effect
Fluorouracil
Ovarian cancer
Radiation therapy
Biochemistry
Cisplatin
Epidermal growth factor receptor
Gene
Genetics
Hysterectomy
Lung cancer
Nursing